TerminatedNCT04955470
Ketamine Infusion for Rapid Reduction of Suicide prevention in Pediatrics
Medication studyAges 10–17Canada
Understand this study
Who could participate?
Listed age limits: 10 years to 17 years.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 1, 2022
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 15
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Canada
- Age range
- From 10 Years to 17 Years
- Official registry ID
- NCT04955470
- Official title
Show the full official title
Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics: a Pilot Randomized Controlled Trial
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Does this study involve medication?
Yes. The study involves medication, including Ketamine Injectable Solution, Midazolam Injectable Solution and Normal Saline 0.9% Injectable Solution.
Who can participate?
Listed age limits: 10 years to 17 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicide prevention With Intent
An evaluation trial of ‘iConsiderLife’: A self-help, crisis and Suicide prevention decision-support program to assist in reducing distress in adults.
